Tumour-Infiltrating Lymphocyte Density as a Predictive Biomarker of Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial
Br. J. Cancer 2023 Apr 07;[EPub Ahead of Print], DHW Liu, YW Kim, N Sefcovicova, JP Laye, LC Hewitt, AF Irvine, V Vromen, Y Janssen, N Davarzani, GE Fazzi, S Jolani, V Melotte, DR Magee, MC Kook, H Kim, R Langer, JH Cheong, HI GrabschFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.